期刊
ADVANCES IN CHRONIC KIDNEY DISEASE
卷 26, 期 1, 页码 35-40出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ackd.2018.09.004
关键词
Infectious disease; Kidney transplant; Chronic kidney disease; Mycobacterium tuberculosis (TB); Nontuberculous mycobacteria (NTM)
Patients with chronic kidney disease have impaired immunity that increases their risk of infection. Increased incidence of mycobacterial infections, in particular Mycobacterium tuberculosis, is described in patients undergoing hemodialysis and peritoneal dialysis as well as after kidney transplantation in low-prevalence and high-prevalence settings. Diagnosis of this infection can be challenging because of atypical presentations that may lead to treatment delay and, consequently, increased mortality; however, recent advances in molecular testing have improved diagnostic accuracy. It is imperative to try to identify those patients at increased risk and offer adequate prophylaxis. There are controversies and insufficient data regarding treatment agents, duration, and dosages. Most studies in nontuberculous mycobacteria are based on case series and retrospective studies. (C) 2018 by the National Kidney Foundation, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据